Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: Inhibition of proliferation, adhesion, and motility

Endocrine-Related Cancer

Volumn 16, Issue 3, 2009, Pages 795-808

  Massoner, Petra ^a   Colleselli, Daniela ^a   Matscheski, Andrea ^b   Pircher, Haymo ^b   Geley, Stephan ^a   Dürr, Pidder Jansen ^b   Klocker, Helmut ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SOMATOMEDIN BINDING PROTEIN 3;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

CELL ADHESION; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; EXTRACELLULAR MATRIX; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 72749095742     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-08-0175     Document Type: Article

References (51)

1. Alami N, Page V, Yu Q, Jerome L, Paterson J, Shiry L & Leyland-Jones B 2008 Recombinant human insulin-like growth factor-binding protein 3 inhibits tumor growth and targets the Akt pathway in lung and colon cancer models. Growth Hormone & IGF Research 18 487-496.
2. Baxter RC 1990 Glycosaminoglycans inhibit formation of the 140 kDa insulin-like growth factor-binding protein complex. Biochemical Journal 271 773-777.
3. Beattie J, Phillips K, Shand JH, Szymanowska M, Flint DJ & Allan GJ 2005 Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein-3/5 (IGFBP-3/5) heparin axis. Journal of Molecular Endocrinology 34 163-175. (Pubitemid 40305558)
4. Benini S, Zuntini M, Manara MC, Cohen P, Nicoletti G, Nanni P, Oh Y, Picci P & Scotlandi K 2006 Insulin-like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcoma. International Journal of Cancer 119 1039-1046. (Pubitemid 44116910)
5. Bhattacharyya N, Pechhold K, Shahjee H, Zappala G, Elbi C, Raaka B, Wiench M, Hong J & Rechler MM 2006 Nonsecreted insulin-like growth factor binding protein-3 (IGFBP-3) can induce apoptosis in human prostate cancer cells by IGF-independent mechanisms without being concentrated in the nucleus. Journal of Biological Chemistry 281 24588-24601. (Pubitemid 44274233)
6. Boyle BJ, Zhao XY, Cohen P & Feldman D 2001 Insulin-like growth factor binding protein-3 mediates 1 alpha,25- dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1. Journal of Urology 165 1319-1324. (Pubitemid 32210283)
7. Burrows C, Holly JM, Laurence NJ, Vernon EG, Carter JV, Clark MA, McIntosh J, McCaig C, Winters ZE & Perks CM 2006 Insulin-like growth factor binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial cells that are each reversible and dependent upon cholesterol-stabilized integrin receptor complexes. Endocrinology 147 3484-3500. (Pubitemid 43901140)
8. Butt AJ & Williams AC 2001 IGFBP-3 and apoptosis - a license to kill? Apoptosis 6 199-205.
9. Butt AJ, Firth SM, King MA & Baxter RC 2000 Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. Journal of Biological Chemistry 275 39174-39181.
10. Cattaruzza S & Perris R 2005 Proteoglycan control of cell movement during wound healing and cancer spreading. Matrix Biology 24 400-417. (Pubitemid 41765019)
11. Cohen P, Graves HC, Peehl DM, Kamarei M, Giudice LC & Rosenfeld RG 1992 Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. Journal of Clinical Endocrinology and Metabolism 75 1046-1053.
12. Gennigens C, Menetrier-Caux C & Droz JP 2006 Insulin-like growth factor (IGF) family and prostate cancer. Critical Reviews in Oncology/Hematology 58 124-145.
13. Gui Y & Murphy LJ 2001 Insulin-like growth factor (IGF)- binding protein-3 (IGFBP-3) binds to fibronectin (FN): demonstration of IGF-I/IGFBP-3/fn ternary complexes in human plasma. Journal of Clinical Endocrinology and Metabolism 86 2104-2110. (Pubitemid 32472927)
14. Hanahan D & Weinberg RA 2000 The hallmarks of cancer. Cell 100 57-70.
15. Hong J, Zhang G, Dong F & Rechler MM 2002 Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. Journal of Biological Chemistry 277 10489-10497. (Pubitemid 34968171)
16. Hwa V, Oh Y & Rosenfeld RG 1999 The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocrine Reviews 20 761-787. (Pubitemid 30648894)
17. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T & Thun MJ 2008 Cancer statistics, 2008. CA: A Cancer Journal for Clinicians 58 71-96.
18. Jones JI & Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 16 3-34.
19. Juliano RL, Reddig P, Alahari S, Edin M, Howe A & Aplin A 2004 Integrin regulation of cell signalling and motility. Biochemical Society Transactions 32 443-446. (Pubitemid 38813533)
20. Jurgeit A, Berlato C, Obrist P, Ploner C, Massoner P, Schmolzer J, Haffner MC, Klocker H, Huber LA, Geley S et al. 2007 Insulin-like growth factor-binding protein-5 enters vesicular structures but not the nucleus. Traffic 8 1815-1828. (Pubitemid 350066691)
21. Kojima S, Mulholland DJ, Ettinger S, Fazli L, Nelson CC & Gleave ME 2006 Differential regulation of IGFBP-3 by the androgen receptor in the lineage-related androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer models. Prostate 66 971-986. (Pubitemid 43853069)
22. Lackey J, Barnett J, Davidson L, Batty IH, Leslie NR & Downes CP 2007 Loss of PTEN selectively desensitizes upstream IGF1 and insulin signaling. Oncogene 26 7132-7142. (Pubitemid 350059678)
23. Lee KW, Liu B, Ma L, Li H, Bang P, Koeffler HP & Cohen P 2004 Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. Journal of Biological Chemistry 279 469-476. (Pubitemid 38044848)
24. Liu B, Weinzimer SA, Gibson TB, Mascarenhas D & Cohen P 2003 Type Ialpha collagen is an IGFBP-3 binding protein. Growth Hormone & IGF Research 13 89-97. (Pubitemid 36701654)
25. Liu B, Lee KW, Anzo M, Zhang B, Zi X, Tao Y, Shiry L, Pollak M, Lin S & Cohen P 2007 Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis. Oncogene 26 1811-1819. (Pubitemid 46426204)
26. Martin JA & Buckwalter JA 2000 The role of chondrocyte- matrix interactions in maintaining and repairing articular cartilage. Biorheology 37 129-140.
27. Massoner P, Haag P, Seifarth C, Jurgeit A, Rogatsch H, Doppler W, Bartsch G & Klocker H 2008 Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction. Prostate 68 1165-1178.
28. Matsumoto K, Ziober BL, Yao CC & Kramer RH 1995 Growth factor regulation of integrin-mediated cell motility. Cancer Metastasis Reviews 14 205-217.
29. McCaig C, Perks CM & Holly JM 2002 Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin. Journal of Cell Science 115 4293-4303. (Pubitemid 35460700)
30. Oh Y, Muller HL, Lamson G & Rosenfeld RG 1993 Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. Journal of Biological Chemistry 268 14964-14971. (Pubitemid 23206645)
31. Oh Y, Gucev Z, Ng L, Muller HL & Rosenfeld RG 1995 Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells. Progress in Growth Factor Research 6 503-512.
32. Oh SH, Lee OH, Schroeder CP, Oh YW, Ke S, Cha HJ, Park RW, Onn A, Herbst RS, Li C et al. 2006 Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-- like growth factor-independent urokinase-type plasminogen activator inhibition. Molecular Cancer Therapeutics 5 2685-2695. (Pubitemid 44848995)
33. Parkin DM, Bray F, Ferlay J & Pisani P 2005 Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians 55 74-108.
34. Peng L, Wang J, Malloy PJ & Feldman D 2007 The role of insulin-like growth factor binding protein-3 in the growth inhibitory actions of androgens in LNCaP human prostate cancer cells. International Journal of Cancer 122 558-566. (Pubitemid 350308946)
35. Rajah R, Valentinis B & Cohen P 1997 Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. Journal of Biological Chemistry 272 12181-12188. (Pubitemid 27202802)
36. Ramsay AG, Marshall JF & Hart IR 2007 Integrin trafficking and its role in cancer metastasis. Cancer Metastasis Reviews 26 567-578. (Pubitemid 350115108)
37. Rasband WS 1997-2007 ImageJ. edn 1.38r. Bethesda, Maryland, USA: US National Institutes of Health.
38. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM & Egger M 2004 Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363 1346-1353.
39. Rood PM, Calafat J, von dem Borne AE, Gerritsen WR & van der Schoot CE 2000 Immortalisation of human bone marrow endothelial cells: characterisation of new cell lines. European Journal of Clinical Investigation 30 618-629.
40. Rowley DR 1998 What might a stromal response mean to prostate cancer progression? Cancer Metastasis Reviews 17 411-419.
41. Sansal I & Sellers WR 2004 The biology and clinical relevance of the PTEN tumor suppressor pathway. Journal of Clinical Oncology 22 2954-2963. (Pubitemid 41079915)
42. Selman SH 2000 "Latent" carcinoma of the prostate: a medical misnomer? Urology 56 708-711.
43. Silha JV, Sheppard PC, Mishra S, Gui Y, Schwartz J, Dodd JG & Murphy LJ 2006 Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms. Endocrinology 147 2112-2121.
44. Smith EP, Lu L, Chernausek SD & Klein DJ 1994 Insulin-like growth factor-binding protein-3 (IGFBP-3) concentration in rat Sertoli cell-conditioned medium is regulated by a pathway involving association of IGFBP-3 with cell surface proteoglycans. Endocrinology 135 359-364. (Pubitemid 24203838)
45. Sung SY & Chung LW 2002 Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting. Differentiation 70 506-521. (Pubitemid 36194316)
46. Torng PL, Lee YC, Huang CY, Ye JH, Lin YS, Chu YW, Huang SC, Cohen P, Wu CW & Lin CT 2008 Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma. Oncogene 27 2137-2147.
47. Tuxhorn JA, Ayala GE & Rowley DR 2001 Reactive stroma in prostate cancer progression. Journal of Urology 166 2472-2483. (Pubitemid 33065339)
48. Van Hamme E, Dewerchin HL, Cornelissen E, Verhasselt B & Nauwynck HJ 2008 Clathrin- and caveolae-independent entry of feline infectious peritonitis virus in monocytes depends on dynamin. Journal of General Virology 89 2147-2156.
49. Williams AC, Smartt H, H-Zadeh AM, Macfarlane M, Paraskeva C & Collard TJ 2007 Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-kappaB. Cell Death and Differentiation 14 137-145. (Pubitemid 44911901)
50. Yang YW, Yanagishita M & Rechler MM 1996 Heparin inhibition of insulin-like growth factor-binding protein-3 binding to human fibroblasts and rat glioma cells: role of heparan sulfate proteoglycans. Endocrinology 137 4363-4371. (Pubitemid 26321886)
51. Zappala G, Elbi C, Edwards J, Gorenstein J, Rechler MM & Bhattacharyya N 2008 Induction of apoptosis in human prostate cancer cells by insulin-like growth factor binding protein-3 does not require binding to retinoid X receptor-alpha. Endocrinology 149 1802-1812.